Naproxen
- Product NDC
- 53217-262
- 11-digit product format
- 532170262
- Labeler code
- 53217
- Product ID
- 53217-262_4560e3d4-7e51-42c7-bd30-46c481a751ea
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aidarex Pharmaceuticals LLC
- Application
- ANDA078250
- Marketing category
- ANDA
- Marketing start
- 2007-07-01
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 375 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53217-262-30 | Naproxen | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
| 53217-262-60 | Naproxen | 60 in 1 BOTTLE | TABLET | 60 | | 1 |
| 53217-262-90 | Naproxen | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53217-262 | NAPROXEN TABLET [AIDAREX PHARMACEUTICALS LLC] | 1 | Legacy NDC, 3 package rows | 20170313_26105acc-4025-4bcd-b484-1d87609bd7b6.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 53217-262-30 | 53217026230 | 30 in 1 BOTTLE | Historical |
| 53217-262-60 | 53217026260 | 60 in 1 BOTTLE | Historical |
| 53217-262-90 | 53217026290 | 90 in 1 BOTTLE | Historical |